To exclude that the association between PTX3 and JAK2V617F homozygous mutation could be affected by other risk factors, we tested whether this relationship remained statistically significant after adjustment for diagnosis (PV vs. ET), gender, age and mutations (JAK2V617F homozygous vs. other mutations) in a multivariate model. Here, PTX3 is linked to essential thrombocythemia.